Compounds > fluorescein-5-isothiocyanate
Page last updated: 2024-08-22

fluorescein-5-isothiocyanate and gefitinib

fluorescein-5-isothiocyanate has been researched along with gefitinib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albanell, J; Anido, J; Arribas, J; Averbuch, S; Baselga, J; Guzmán, M; Matar, P; Rojo, F1
Bailey, KE; Cai, Z; Chen, Z; Costantini, DL; Reilly, RM; Scollard, DA; Vallis, KA1
Chang, J; Shi, Y; Su, C; Yang, G; Zhao, L1

Other Studies

3 other study(ies) available for fluorescein-5-isothiocyanate and gefitinib

ArticleYear
ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Division; Cell Line, Tumor; Dimerization; Dose-Response Relationship, Drug; ErbB Receptors; Flow Cytometry; Fluorescein-5-isothiocyanate; Gefitinib; Humans; Ligands; Models, Biological; Neuregulin-1; Phosphorylation; Precipitin Tests; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Signal Transduction; Time Factors

2003
Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:9

    Topics: Antineoplastic Agents; Cell Compartmentation; Cell Line, Tumor; Cell Nucleus; Electrons; Epidermal Growth Factor; ErbB Receptors; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gefitinib; Humans; Indium Radioisotopes; Pentetic Acid; Phosphorylation; Protein Transport; Quinazolines; Radiopharmaceuticals; Signal Transduction

2007
Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance.
    Journal of nanobiotechnology, 2015, Sep-22, Volume: 13

    Topics: Adenosine Triphosphate; Annexin A5; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Chitosan; Chloroquine; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; Fluorescein-5-isothiocyanate; Gefitinib; Humans; Intracellular Space; Nanoparticles; Necrosis; Quinazolines

2015